Clinical Trial Update: Efficacy, Safety and Satisfaction of VITAROS (Transdermal Topical Alprostadil) in Men With Erectile Dysfunction [Phase 4]

View source ↗

Summary

The Phase 4 trial evaluating VITAROS (transdermal topical alprostadil) for erectile dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• VITAROS (alprostadil)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Erectile Dysfunction | Phase 4 | Status: WITHDRAWN